Search

everythinglearnresearchcommunity

for

Search:↓

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Stress can slow hair growth by affecting certain cells and pathways.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Hair follicles significantly affect the skin absorption of some drugs.

Vitamin C derivative helps hair grow longer by making cells produce a growth factor through a specific cellular pathway.

Nanocarriers improve skin disease treatment by targeting hair follicles effectively.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Notch pathway activation causes abnormal hair layer development.

Caffeine in shampoo quickly enters the body through hair follicles.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Pilomatricoma can develop into various hair-related structures.

Modified frameworks with stearic acid enhance drug delivery and promote hair growth.

Natural extracts may promote hair growth with fewer side effects than conventional treatments.

Exposure to particulate matter worsens postpartum hair loss by affecting inflammation and cell death pathways.

SesZen-Bio™ may be a promising and safer option for promoting hair growth.

Activating β-catenin and inactivating PTEN cause follicular tumors, not papillomas, similar to those in Cowden’s Disease.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

New biological pathways and potential treatment targets for male pattern baldness were identified.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

SPRY1 deficiency in skin cells causes stem cells to move to the skin surface, leading to increased pigmentation.

Removing Lrig1-positive cells in mice leads to temporary loss of sebaceous glands.

New regenerative treatments show promise in improving hair growth for androgenetic alopecia.

Recombinant type XVII collagen may help regrow hair by activating specific cell pathways.

A new microneedle system effectively delivers finasteride to treat hair loss.

Lagerstroemia indica extract can help prevent hair loss and promote hair growth.

Targeting the PIEZO1 and MLCK axis may offer a new treatment for hair loss.